Reference is made to SoftOx Solution's ("Company") announcement today regarding
the Company's contemplated in-kind dividend of 1 951 253 942 shares in the
Company's subsidiary SoftOx Wound & Skin Cares on a 1:1 basis such that 1
Company share will entitle to dividend of 1 SoftOx Wound & Skin Care share.
Please find the key information relating to the dividend in-kind below: 

Dividend amount: NOK 0.00512 per share in the Company (1 share in the Company
will entitle to an in-kind dividend of 1 share in Softox Wound & Skin Care
valued at NOK 0.00512 per share) 

Announced currency: N/A (in-kind distribution) 

Last trading day including the right to dividend: 23 December 2024 

Ex-date: 27 December 2024 

Record date: 30 December 2024 

Dividend payment date: On or about 11 February 2025  

Date of shareholders meeting: 20 December 2024 

Other information: 

The dividend is conditioned on the shareholder's meeting to be held on 20
December 2024 to approve the proposed dividend-in-kind. 

This information is published in accordance with the requirements of the
Continuing Obligations. 

About SoftOx Solutions AS:  

SoftOx Solutions AS (SoftOx) is a medtech and pharmaceutical company listed on
Euronext Growth Oslo under 'SOFTX'. SoftOx Solutions AS was founded in 2012 and
is headquartered in Oslo. The SoftOx Solutions Group includes the holding
company SoftOx Solutions AS, subsidiaries SoftOx Defense Solutions AS and SoftOx
Wound & Skin Care AS, and a Swedish subsidiary Water Innovation AB (WIAB).
SoftOx is developing highly effective antimicrobial solutions for use in
biofilm, viral, and antimicrobial-resistant infections. The patent-protected
technology is based on extensive research and development in partnership with
leading Nordic research institutes.  

For more information on SoftOx, visit www.soft-ox.com